These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity. Cottagiri M; Nyandjo M; Stephens M; Mantilla JJ; Saito H; Mackay IR; Rose NR; Njoku DB Cell Mol Immunol; 2019 Aug; 16(8):706-717. PubMed ID: 30030493 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow mesenchymal stem cell-derived exosomes alleviate skin fibrosis in systemic sclerosis by inhibiting the IL-33/ST2 axis via the delivery of microRNA-214. Xie L; Long X; Mo M; Jiang J; Zhang Q; Long M; Li M Mol Immunol; 2023 May; 157():146-157. PubMed ID: 37028129 [TBL] [Abstract][Full Text] [Related]
7. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Aliprantis AO; Wang J; Fathman JW; Lemaire R; Dorfman DM; Lafyatis R; Glimcher LH Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2827-30. PubMed ID: 17307869 [TBL] [Abstract][Full Text] [Related]
8. Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells. Saigusa R; Asano Y; Taniguchi T; Hirabayashi M; Nakamura K; Miura S; Yamashita T; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Trojanowska M; Sato S Arthritis Res Ther; 2018 Feb; 20(1):23. PubMed ID: 29415756 [TBL] [Abstract][Full Text] [Related]
9. Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma. Aung WW; Wang C; Xibei J; Horii M; Mizumaki K; Kano M; Okamura A; Kobayashi T; Matsushita T J Dermatol Sci; 2021 Mar; 101(3):174-184. PubMed ID: 33451905 [TBL] [Abstract][Full Text] [Related]
10. IL-33/ST2 Axis in Organ Fibrosis. Kotsiou OS; Gourgoulianis KI; Zarogiannis SG Front Immunol; 2018; 9():2432. PubMed ID: 30405626 [TBL] [Abstract][Full Text] [Related]
12. Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease. Yang J; Ramadan A; Reichenbach DK; Loschi M; Zhang J; Griesenauer B; Liu H; Hippen KL; Blazar BR; Paczesny S JCI Insight; 2019 Mar; 4(5):. PubMed ID: 30694220 [TBL] [Abstract][Full Text] [Related]
13. The alarmins IL-1 and IL-33 differentially regulate the functional specialisation of Foxp3 Alvarez F; Istomine R; Shourian M; Pavey N; Al-Aubodah TA; Qureshi S; Fritz JH; Piccirillo CA Mucosal Immunol; 2019 May; 12(3):746-760. PubMed ID: 30872761 [TBL] [Abstract][Full Text] [Related]
14. Potential roles of interleukin-17A in the development of skin fibrosis in mice. Okamoto Y; Hasegawa M; Matsushita T; Hamaguchi Y; Huu DL; Iwakura Y; Fujimoto M; Takehara K Arthritis Rheum; 2012 Nov; 64(11):3726-35. PubMed ID: 22833167 [TBL] [Abstract][Full Text] [Related]
15. An ST2-dependent role of bone marrow-derived group 2 innate lymphoid cells in pulmonary fibrosis. Zhao Y; De Los Santos FG; Wu Z; Liu T; Phan SH J Pathol; 2018 Aug; 245(4):399-409. PubMed ID: 29722022 [TBL] [Abstract][Full Text] [Related]
16. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Pastille E; Wasmer MH; Adamczyk A; Vu VP; Mager LF; Phuong NNT; Palmieri V; Simillion C; Hansen W; Kasper S; Schuler M; Muggli B; McCoy KD; Buer J; Zlobec I; Westendorf AM; Krebs P Mucosal Immunol; 2019 Jul; 12(4):990-1003. PubMed ID: 31165767 [TBL] [Abstract][Full Text] [Related]
17. Brain Foxp3 Guo S; Luo Y Int Immunopharmacol; 2020 Apr; 81():106027. PubMed ID: 31791672 [TBL] [Abstract][Full Text] [Related]
18. The function of IL-33/ST2 signaling axis in treg cells activating fibrosis in IgG4-related disease. Wu Y; Liu J; Yu T; Zhang J; Jin X; Ye Y; Zhang R; Wang L Hum Immunol; 2022 Apr; 83(4):295-305. PubMed ID: 35067387 [TBL] [Abstract][Full Text] [Related]
19. IL-33 Drives Expansion of Type 2 Innate Lymphoid Cells and Regulatory T Cells and Protects Mice From Severe, Acute Colitis. Ngo Thi Phuong N; Palmieri V; Adamczyk A; Klopfleisch R; Langhorst J; Hansen W; Westendorf AM; Pastille E Front Immunol; 2021; 12():669787. PubMed ID: 34335571 [TBL] [Abstract][Full Text] [Related]
20. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis. Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]